South Africa In-Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers South Africa In-Vitro Diagnostics Companies and it is segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Other Test Types), Product (Instruments, Reagents, and Other Products), Usability (Disposable IVD Devices and Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Other Applications), and End User (Diagnostic Laboratories, Hospitals and Clinics, and Other End Users). The market size and the value (in USD million) for the above segments.

South Africa In-Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

South Africa In-Vitro Diagnostics (IVD) Industry Overview

The In-vitro Diagnostics market in South Africa is fragmented in nature. This is majorly due to the rising investment of global companies in South Africa as this country shows several opportunities for growth. With the rising expansion strategies that are being implemented by the companies, it is expected that in the future, several small and mid-sized companies will penetrate the market and hold a substantial share. The major players in the market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Thermo Fisher Scientific, and Nihon Kohden Corporation among others.

South Africa In-Vitro Diagnostics (IVD) Market Leaders

  1. Nihon Kohden Corporation

  2. Siemens Healthineers

  3. Thermo Fisher Scientific

  4. Abbott Laboratories

  5. F. Hoffmann-La Roche Ltd

  6. *Disclaimer: Major Players sorted in no particular order
South Africa In-Vitro Diagnostics Market Concentration

South Africa In-Vitro Diagnostics Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?